page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

ZOFRAN (ondansetron hydrochloride)

Category:

  • Selective 5-HT 3 receptor antagonist

Description:

  • Antiemetic

Indications:

  • Nausea

Contraindications:

  • Sensitivies to selective 5-HT 3 receptor antagonists

Precautions:

  • Pregnancy category B

Adverse Reactions (Side Effects):

  • Headache

  • Malaise

  • Fatigue

  • Constipation

Dosage:

  • Adult:   

    • 8 mg PO up to TID prn nausea

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site